1968
DOI: 10.1016/0002-8703(68)90206-8
|View full text |Cite
|
Sign up to set email alerts
|

Testing in hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1970
1970
1974
1974

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 72 publications
0
1
0
Order By: Relevance
“…A discrepancy between the excretion of endogenous normetanephrine and the levels of 3 H-normetanephrine found in the urine after intravenous injection of 3 H-NE may exist not only in DOCA-salt hypertension but under selected conditions also in human hypertension (22,23). The difficulty with studying the fate of 3 H-NE in this fashion is that its tissue distribution will be proportional to blood flow (24) so that a more rapid disappearance of 3 H-NE from plasma may be due in large part to clearance and destruction in kidney and liver as well as uptake in organs such as heart (24).…”
Section: Discussionmentioning
confidence: 99%
“…A discrepancy between the excretion of endogenous normetanephrine and the levels of 3 H-normetanephrine found in the urine after intravenous injection of 3 H-NE may exist not only in DOCA-salt hypertension but under selected conditions also in human hypertension (22,23). The difficulty with studying the fate of 3 H-NE in this fashion is that its tissue distribution will be proportional to blood flow (24) so that a more rapid disappearance of 3 H-NE from plasma may be due in large part to clearance and destruction in kidney and liver as well as uptake in organs such as heart (24).…”
Section: Discussionmentioning
confidence: 99%